THE NATIONAL ACADEMIES PRESS
500 Fifth Street, N.W.
Washington, DC 20001
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance.
This study was supported by Contract 200-2005-13434, TO#16, between the National Academy of Sciences and the Department of Health and Human Services (with support from the Centers for Disease Control and Prevention, the Office of Minority Health, and the Department of Veterans Affairs) and by the Task Force for Child Survival and Development on behalf of the National Viral Hepatitis Roundtable. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that provided support for this project.
Library of Congress Cataloging-in-Publication Data
Hepatitis and liver cancer : a national strategy for prevention and control of hepatitis B and C / Heather M. Colvin and Abigail E. Mitchell, editors ; Committee on the Prevention and Control of Viral Hepatitis Infections, Board on Population Health and Public Health Practice.
p. ; cm.
Includes bibliographical references and index.
1. Hepatitis B—United States. 2. Hepatitis C—United States. 3. Liver—Cancer—United States. I. Colvin, Heather M. II. Mitchell, Abigail E. III. Institute of Medicine (U.S.). Committee on the Prevention and Control of Viral Hepatitis Infections. IV. Institute of Medicine (U.S.). Board on Population Health and Public Health Practice. V. National Academies Press (U.S.)
[DNLM: 1. Hepatitis B—complications—United States. 2. Hepatitis B—prevention & control—United States. 3. Hepatitis C—complications—United States. 4. Hepatitis C— prevention & control—United States. 5. Liver Neoplasms—prevention & control—United States. 6. Viral Hepatitis Vaccines—therapeutic use—United States. WC 536 H5322 2010]
Additional copies of this report are available from the
National Academies Press,
500 Fifth Street, N.W., Lockbox 285, Washington, DC 20055; (800) 624-6242 or (202) 334-3313 (in the Washington metropolitan area); Internet, http://www.nap.edu.
For more information about the Institute of Medicine, visit the IOM home page at www.iom.edu.
Copyright 2010 by the National Academy of Sciences. All rights reserved.
Printed in the United States of America
The serpent has been a symbol of long life, healing, and knowledge among almost all cultures and religions since the beginning of recorded history. The serpent adopted as a logotype by the Institute of Medicine is a relief carving from ancient Greece, now held by the Staatliche Museen in Berlin.
Suggested citation: IOM (Institute of Medicine). 2010. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. Washington, DC: The National Academies Press.